BMP9 mediates the anticancer activity of evodiamine through HIF-1α/p53 in human colon cancer cells

Colon cancer is one of the most common malignancies. Although there has been great development in treatment regimens over the last few decades, its prognosis remains poor. There is still a clinical need to find new drugs for colon cancer. Evodiamine (Evo) is a quinolone alkaloid extracted from the t...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Fu-Shu, Huang, Jun, Cui, Mao-Zhi, Zeng, Jin-Ru, Li, Pei-Pei, Li, Ling, Deng, Yan, Hu, Ying, He, Bai-Cheng, Shu, De-Zhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6967201/
https://www.ncbi.nlm.nih.gov/pubmed/31894286
http://dx.doi.org/10.3892/or.2019.7427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6967201/
https://www.ncbi.nlm.nih.gov/pubmed/31894286
http://dx.doi.org/10.3892/or.2019.7427

Ejemplares similares